14 December 2022 | News
Dr Panchal will be assuming the new role starting January 2023
AstraZeneca Pharma India has announced a change in its leadership with the appointment of Dr Sanjeev Panchal as Country President & Managing Director (MD), with effect from 1st January 2023.
Dr Panchal has been with AstraZeneca for 19 years and began his career in India back in 2003 as a Brand Associate. Over time, he progressed through several positions in India, Indonesia, Asia Pacific and International region, based in Singapore and the UK.
He is currently the Country President for AstraZeneca Malaysia, where he has been instrumental in transforming the business, by driving new launches, innovative patient centric partnerships and Market Access strategies, guiding an inclusive and diverse team to achieve double digit growth outpacing market.
Dr Panchal played a critical role in supporting the government in combating the pandemic through AstraZeneca’s COVID-19 vaccine and long-acting monoclonal antibodies, as well as leading the Corporate Affairs strategy and sustainability initiatives.
He is a Science graduate (BSc) with Post Graduation and Doctorate in Business Administration (PhD). Dr Panchal will be assuming the new role starting January 2023 and will be taking forward the commitment of the organisation in the country.